A primer on critical care pharmacy services

Annals of Pharmacotherapy

Volumn 42, Issue 12, 2008, Pages 1871-1881

  Erstad, Brian L ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

Critical care; Interdisciplinary pharmacy practice

Indexed keywords

CERTIFICATION; CLINICAL RESEARCH; COST EFFECTIVENESS ANALYSIS; DECENTRALIZATION; DECISION MAKING; HISTORY; INTENSIVE CARE UNIT; INTERDISCIPLINARY PHARMACY PRACTICE; JOB SATISFACTION; PATIENT SAFETY; PHARMACIST; PHARMACY; PRIORITY JOURNAL; PROFESSIONAL DEVELOPMENT; RESIDENCY EDUCATION; REVIEW; UNIVERSITY HOSPITAL;

CRITICAL CARE; DECISION MAKING; EDUCATION, PHARMACY; HUMANS; INTENSIVE CARE UNITS; PATIENT CARE TEAM; PHARMACISTS; PHARMACY SERVICE, HOSPITAL; PROFESSIONAL ROLE;

EID: 57449104170     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1L375     Document Type: Review

References (52)

1. Whitney HAK Jr, Nahata MC, Thordsen DJ. Francke's legacy - 40 years of clinical pharmacy. Ann Pharmacother 2008;42:121-6. Epub 19 Dec 2007. DOI 10.1345/aph.1K660
2. Smith WE. Clinical pharmacy: reflections and forecasts. Ann Pharmacother 2007;41:325-8. Epub 6 Feb 2007. DOI 10.1345/aph.1H624
3. Dasta JF. Critical care. Ann Pharmacother 2006;40:736-7. Epub 28 Mar 2006. DOI 10.1345/aph.1G394
4. Weber RJ, Kane SL, Oriolo VA, Saul M, Skledar SJ, Dasta JF. Impact of intensive care unit (ICU) drug use on hospital costs: a descriptive analysis, with recommendations for optimizing ICU pharmacotherapy. Crit Care Med 2003;31(suppl):S17-24.
5. Pedersen CA, Schneider PJ, Santell JP, Kelly EJ. ASHP national survey of pharmacy practice in acute care settings: monitoring, patient education, and wellness - 2000. Am J Health-Syst Pharm 2000;57:2171-87.
6. MacLaren R, Devlin JW, Martin SJ, Dasta JF, Rudis MI, Bond CA. Critical care pharmacy services in United States hospitals. Ann Pharmacother 2006;40:612-8. Epub 28 Mar 2006. DOI 10.1345/aph.1G590
7. Rudis MI, Brandl KM. Position paper on critical care pharmacy services. Crit Care Med 2000;28:3746-50.
8. Brilli RJ, Spevetz A, Branson RD, et al. Critical care delivery in the intensive care unit: defining clinical roles and the best practice model. Crit Care Med 2001;29:2007-19.
9. Dasta JF, Segal R, Cunningham A. National survey of critical-care pharmaceutical services. Am J Hosp Pharm 1989;46:2308-12.
10. Kopp BJ, Mrsan M, Erstad BL, Duby JJ. Cost implications of and potential adverse events prevented by interventions of a critical care pharmacist. Am J Health Syst Pharm 2007;64:2483-7.
11. Kane-Gill S, Rea RS, Verrico MM, Weber RJ. Adverse-drug event rates for high-cost and high-use drugs in the intensive care unit. Am J Health Syst Pharm 2006;63:1876-81.
12. Horn E, Jacobi J. The critical care pharmacist: evolution of an essential team member. Crit Care Med 2006;34(suppl):S46-51.
13. Patel G, Loh-Trivedi M. Clinical pharmacists in the intensive care unit: is there really an equation? Intensive Care Med 2006;32:1275-6.
14. Schumock GT, Butler MG, Meek PD, Vermeulen LC, Arondekar BV, Bauman JL. Evidence of the economic benefit of clinical pharmacy services: 1996-2000. Pharmacotherapy 2003;23:113-32.
15. Kane SL, Weber RJ, Dasta JF. The impact of critical care pharmacists on enhancing patient outcomes. Intensive Care Med 2003;29:691-8.
16. De Rudy T, Willems L, Simoens S. Economic effects of clinical pharmacy interventions: a literature review. Am J Health Syst Pharm 2008;65:1161-72.
17. Schumock GT, Stubbings J. How to develop a business plan for pharmacy services. 1st ed. Kansas City, MO: American College of Clinical Pharmacy, 2007.
18. PGY1 outcomes, goals, and objectives: pharmacy residency (PGY1). American Society of Health-System Pharmacists. www.ashp.org/s_ashp/cat1c.asp?CID= 3549&DID=5577 (accessed 2008 May 9).
19. Report to Congress. The Critical Care Workforce: a study of the supply and demand for critical care physicians. http://bhpr.hrsa.gov/healthworkforce/ reports/criticalcare/cc1.htm (accessed 2008 Jun 7).
20. Pharmacy Manpower Project. Aggregate Demand Index. www.pharmacymanpower. com (accessed 2008 May 13).
21. Delaney A, Bagshaw SM, Ferland A, Laupland K, Manns B, Doig C. The quality of reports of critical care meta-analyses in the Cochrane Database of Systematic Reviews: an independent appraisal. Crit Care Med 2007;35:589-94.
22. Pedersen CA, Schneider PJ, Scheckelhoff DJ. ASHP national survey of pharmacy practice in hospital settings: prescribing and transcribing - 2007. Am J Health Syst Pharm 2008;65:827-43.
23. Sinuff T, Patel RV, Adhikari NKJ, Meade MO, Schunemann HJ, Cook DJ. Quality of professional society guidelines and consensus conference statements in critical care. Crit Care Med 2008;36:1049-58.
24. Guyatt G, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336:924-6.
25. Guyatt G, Gutterman D, Baumann MH, et al. Grading strength of recommendations and quality of evidence in clinical guidelines. Chest 2006;129:174-81.
26. American Society of Health-System Pharmacists. ASHP therapeutic guidelines on stress ulcer prophylaxis. Am J Health Syst Pharm 1999;56:347-79.
27. Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock 2008. Crit Care Med 2008;36:296-327.
28. Jacobi J, Fraser GL, Coursin DB, et al. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med 2002;30:119-41.
29. Murray MJ, Cowen J, DeBlock H, et al. Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient. Crit Care Med 2002;30:142-56.
30. Erstad BL, Martin SJ, Brophy G, et al. Key articles and guidelines relative to intensive care unit pharmacology - 2004. Pharmacotherapy 2005;25:585-610.
31. Marshall J, Finn CA, Theodore AC. Impact of a clinical pharmacist-enforced intensive care unit sedation protocol on duration of mechanical ventilation and hospital stay. Crit Care Med 2008;36:427-33.
32. Rea RS, Donihi AC, Bobeck M, et al. Implementing an intravenous insulin infusion protocol in the intensive care unit. Am J Health Syst Pharm 2007;64:385-95.
33. Kane-Gill SL, Devlin JW. Adverse drug event reporting in intensive care units: a survey of current practices. Ann Pharmacother 2006;40:1267-73. Epub 18 Jul 2006. DOI 10.1345/aph.1H088
34. Rothschild JM, Landrigan CP, Cronin JW, et al. The Critical Care Safety Study: the incidence and nature of adverse events and serious medical errors in intensive care. Crit Care Med 2005;32:1694-700.
35. Pronovost P, Holzmueller CG, Needham DM, et al. How will we know patients are safer? An organization-wide approach to measuring and improving safety. Crit Care Med 2006;34:1988-95.
36. Shojania KG, Duncan BW, McDonald KM, et al., eds. Making health care safer: a critical analysis of patient safety practices. Evidence Report/Technology Assessment No. 43 (Prepared by the University of California at San Francisco - Stanford Evidence-based Practice Center under Contract No. 290-97-0013), AHRQ Publication No. 01-E058, Rockville, MD: Agency for Healthcare Research and Quality, July 2001.
37. Shojania KG, Duncan BW, McDonald KM, Wachter RM. Safe but sound: patient safety meets evidence-based medicine. JAMA 2002;288: 508-13.
38. Leape LL, Cullen DJ, Clapp MD, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA 1999;282:167-70.
39. Leape LL, Berwick DM, Bates DW. What practices will most improve safety? Evidence-based medicine meets patient safety. JAMA 2002;288:501-7.
40. Pedersen CA, Schneider PJ, Scheckelhoff DJ. ASHP national survey of pharmacy practice in hospital settings: dispensing and administration - 2005. Am J Health Syst Pharm 2006;63:327-45.
41. Dasta J. Critical care therapeutics: a frontier for clinical pharmacy. Drug Intell 1982;16:398-9.
42. PGY2 outcomes, goals, and objectives: critical care pharmacy (PGY2). American Society of Health-System Pharmacists. www.ashp.org/s_ashp/ cat1c.asp?CID=3549&DID=5577 (accessed 2008 May 9).
43. Truog RD. Will ethical requirements bring critical care research to a halt? Intensive Care Med 2005;31:338-44.
44. Overhage MJ, Lukes A. Practical, reliable, comprehensive method for characterizing pharmacists' clinical activities. Am J Health Syst Pharm 1999;56:2444-50.
45. Talmor D, Shapiro N, Greenberg D, Stone PW, Neumann PJ. When is critical care medicine cost-effective? A systematic review of the cost-effectiveness literature. Crit Care Med 2006;34:2738-47.
46. Hofhuis JGM, Spronk PE, van Stel JF, Schrijvers GJP, Rommes JH, Bakker J. The impact of critical illness on perceived health-related quality of life during ICU treatment, hospital stay, and after hospital discharge. Chest 2008;133:377-85.
47. Russell LB, Gold MR, Siegel JE, Daniels N, Weinstein MC. The role of cost-effectiveness analysis in health and medicine. JAMA 1996;276:1172-7.
48. Guyatt G, Baumann M, Pauker S, et al. Addressing resource allocation issues in recommendations from clinical practice guidelines panels. Chest 2006;129:182-7.
49. Dasta JF, McLaughlin TP, Mody SH, Piech CT. Daily cost of an intensive care unit day: the contribution of mechanical ventilation. Crit Care Med 2005;33:1266-71.
50. Second American Thoracic Society Workshop on Outcomes Research. Understanding costs and cost-effectiveness in critical care. Am J Respir Crit Care Med 2002;165:540-50.
51. Revicki DA, Frank L. Pharmacoeconomic evaluation in the real world. Pharmacoeconomics 1999;15:423-34.
52. Kahn JM. Understanding economic outcomes in critical care. Curr Opin Crit Care 2006;12:399-404.